Nancy Joseph-Ridge, MD

Dr. Nancy Joseph-Ridge has more than 25 years of experience in academic clinical research and the pharmaceutical industry. Recently, Nancy was EVP R&D and Chief Medical Officer at TerSera. Prior to Tersera, she was a Corporate Officer and an R&D Executive at Takeda. She was head of CNS, Immunology, and Rheumatology therapeutic areas, responsible for all strategic aspects of R&D for those areas. She was also head of Global Development and was responsible for all aspects of drug development of pipeline and marketed compounds, including clinical sciences, clinical operations, medical, regulatory, pharmacovigilance, project management, and quality. Prior to that, Nancy was President at Takeda Global R&D US, Vice President of R&D at TAP Pharmaceuticals, and held positions in clinical development at Searle/Pharmacia.

Nancy previously served on the Board of iBIO Institute and was chairperson for two years. She also served on the PhRMA Scientific and Regulatory Committee and Chicago Technology Industry Diversity Council. Prior to working in the pharmaceutical industry, she was an Assistant Professor of Medicine at Rush Medical Center and then an Assistant Professor of Clinical Medicine at University of Chicago.

Nancy received her MD from the University of Illinois, completed her internship and residency in Internal Medicine, was chief resident at Rush Medical Center, and then completed her fellowship in Rheumatology at the University of Chicago. She received Board certifications in Internal Medicine and Rheumatology. Nancy has been a member of various professional societies and is currently a Fellow Member of the American College of Rheumatology.